The "Balloon Catheter Market Global Report by Product Type, Indication, Raw Materials, End-User, Countries and Company Analysis 2025-2033" report has been added to ResearchAndMarkets.com's offering.
Balloon Catheter Market is expected to reach US$ 8.51 billion in 2033 from US$ 4.72 billion in 2024, with a CAGR of 6.75% from 2025 to 2033
The market for balloon catheters is expanding worldwide, with North America leading the way because of its sophisticated healthcare system and high rate of cardiovascular disease. Driven by technical developments, Europe comes in second. The Asia Pacific region is expanding quickly due to factors like aging populations, increased incidence of chronic diseases, and easier access to healthcare.
Increased cardiovascular diseases, improvements in minimally invasive surgery, an aging population, technological advancements, expanding healthcare infrastructure, and the need for efficient, affordable medical treatments in diagnostics and therapeutics are some of the factors propelling the balloon catheter market.
The market for balloon catheters is anticipated to be driven by a number of factors, including the growing prevalence of lifestyle disorders like obesity and hypertension, which are major risk factors for the development of cardiovascular diseases and brain aneurysms; the rising incidence of pelvic cancers that affect the urinary system in various capacities; the growing geriatric population base, where age is a major factor in the etiology of disease; and technological innovation in product development, such as the production of drug-coated balloon catheters that aim to deliver drugs at the site of action.
Rising Prevalence of Cardiovascular Diseases
One major factor propelling the balloon catheter market's expansion is the increasing incidence of cardiovascular diseases (CVDs). The World Health Organization (WHO) (2023) estimates that 17.9 million deaths worldwide are attributed to cardiovascular disease (CVD), making it the top cause of mortality globally. Cardiovascular diseases (CVDs), such as peripheral artery disease, heart attacks, and coronary artery disease, are becoming more prevalent as a result of aging populations, unhealthy lifestyles, and an increase in risk factors like obesity, diabetes, and hypertension.
In order to improve blood flow and avoid heart attacks or strokes, balloon catheters are frequently used in angioplasty treatments to treat blocked or restricted arteries. The need for less invasive procedures like balloon angioplasty is anticipated to increase as the prevalence of cardiovascular illnesses rises worldwide. Together with developments in balloon catheter technology, this trend is speeding up market expansion and increasing the range of treatment options accessible to patients and healthcare professionals globally.
Technological Advancements
The market for balloon catheters is expanding due in large part to technological developments. By delivering drugs straight to the desired location and lowering the danger of restenosis (re-narrowing of blood arteries), innovations like drug-coated balloons (DCBs) have improved the efficacy of treatments. Furthermore, performance and patient comfort have increased due to developments in catheter materials, such as more biocompatible, flexible, and long-lasting polymers.
Reduced complications and minimally invasive operations are made possible by the development of smaller, more accurate balloon catheters. Furthermore, improved visualization and precise placement during treatments have been made possible by the use of balloon catheters and cutting-edge imaging technologies like intravascular ultrasonography (IVUS). These innovations in technology result in better patient outcomes, quicker recuperation periods, and a rise in the use of balloon catheter-based therapies.
Growing Minimally Invasive Surgery Trends
One of the main factors propelling the balloon catheter market is the expanding trend of less invasive operations. Procedures with fewer incisions, less stress, and quicker recovery times are becoming more and more popular among patients and healthcare professionals. Doctors may treat illnesses like coronary artery disease and vascular blockages without requiring open surgery thanks to balloon catheters, which are crucial in operations like angioplasty.
By making tiny incisions, these catheters are used to guide the balloon to the desired location, where it is inflated to open up obstructed arteries or passageways. Balloon catheter operations and other minimally invasive techniques are becoming more and more popular as patients desire a faster recovery and a lower risk of problems. This change is helping balloon catheters become more widely used in clinical settings around the world.
Problems with High Cost and Affordability
One major obstacle is the high expense of sophisticated balloon catheter devices, particularly those that use cutting-edge technologies like drug-coated balloons. Compared to more conventional treatment alternatives like stents or straightforward angioplasty, these devices are frequently more costly. Healthcare systems may be burdened by the devices' costs as well as those of the required imaging and procedural equipment, particularly in developing nations with tight healthcare budgets.
The cost of these cutting-edge treatments consequently becomes a deterrent to their broad adoption. Furthermore, many countries' reimbursement systems might not completely cover these procedures, which would further limit patients' access. In order to enable wider accessibility, this financial challenge requires the development of cost-effective alternatives.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 230 |
| Forecast Period | 2024 - 2033 |
| Estimated Market Value (USD) in 2024 | $4.72 Billion |
| Forecasted Market Value (USD) by 2033 | $8.51 Billion |
| Compound Annual Growth Rate | 6.7% |
| Regions Covered | Global |
Company Analysis: Overview, Recent Developments, Revenue
- Abbott Laboratories
- Becton Dickinson and Company
- Cardinal Health
- Teleflex Incorporated
- Medtronic Plc.
- Johnson and Johnson
- Edwards Lifesciences Corporation
- Stryker Corporation
- Smith & Nephew
Key Topics Covered:
1. Introduction
2. Research Methodology
3. Executive Summary
4. Market Dynamics
4.1 Growth Drivers
4.2 Challenges
5. Global Balloon Catheter Market
6. Market Share
6.1 By Product Type
6.2 By Indication
6.3 By Raw Material
6.4 By End Users
6.5 By Countries
7. Product Type
7.1 Normal Balloon Catheter
7.2 Drug Eluting Balloon Catheter
7.3 Cutting Balloon Catheter
7.4 Scoring Balloon Catheter
7.5 Stent Graft Balloon Catheter
7.6 Others
8. Indication
8.1 Coronary Artery Disease
8.2 Peripheral Vascular Disease
9. Raw Material
9.1 Polyurethane
9.2 Nylon
9.3 Others
10. End Users
10.1 Hospitals
10.2 Clinics
10.3 Ambulatory Surgical Centers
10.4 Diagnostic Centers
11. Countries
11.1 North America
11.1.1 United States
11.1.2 Canada
11.2 Europe
11.2.1 France
11.2.2 Germany
11.2.3 Italy
11.2.4 Spain
11.2.5 United Kingdom
11.2.6 Belgium
11.2.7 Netherlands
11.2.8 Turkey
11.3 Asia Pacific
11.3.1 China
11.3.2 Japan
11.3.3 India
11.3.4 South Korea
11.3.5 Thailand
11.3.6 Malaysia
11.3.7 Indonesia
11.3.8 Australia
11.3.9 New Zealand
11.4 Latin America
11.4.1 Brazil
11.4.2 Mexico
11.4.3 Argentina
11.5 Middle East & Africa
11.5.1 Saudi Arabia
11.5.2 UAE
11.5.3 South Africa
11.6 Rest of the World
12. Porter's Five Forces Analysis
12.1 Bargaining Power of Buyers
12.2 Bargaining Power of Suppliers
12.3 Degree of Rivalry
12.4 Threat of New Entrants
12.5 Threat of Substitutes
13. SWOT Analysis
13.1 Strength
13.2 Weakness
13.3 Opportunity
13.4 Threat
14. Key Players Analysis
For more information about this report visit https://www.researchandmarkets.com/r/sgmdxg
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250320669876/en/
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
